Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
you said the posts were misleading, not that you disagreed with how information was interpreted. So what was the misleading parts ?
@Twatcher I just disagee with how you sometimes interpret information.
Davde, what was the misleading bit again ?
"how many of the 17 tests are later flow"
Looks like you didn't even read the title of one of the most important docs for ODX released recently from uk gov. The answers to your questions are in the body of the link below without even going to the page. All are lateral flow tests. All are Rapid.
https://www.gov.uk/government/publications/assessment-and-procurement-of-coronavirus-covid-19-tests/outcome-of-the-evaluation-of-rapid-diagnostic-assays-for-specific-sars-cov-2-antigens-lateral-flow-devices
And counting the tests again, there are actually 19 tests there that potential customers can pick from.
@BH normally would ignore, but 2 posts today have been misleading rather than just negative imv!
@Twatcher how many of the 17 available test s are lateral flow, how long does result take and what cost, not as much competition as you are suggesting!
In the scenario whereby Mologic test has been deemed not good enough to get phase3a validation (never mind then selected as a gov test), and there are 17 tests that uk gov have passed phase3a validation, most people looking for a good test will check out the 17 tests firsts.
"Comp, do we need PHE approval to sell the Visitect test?
Don’t think we do, it’s driven by the CE certificate."
CE/UKCA certification only applies (with the exception of a very small number of medical devices, e.g. pregnancy tests or blood sugar test devices) to professional use. If the medical device is intended for non-professional use then further authorisation from MHRA is required.
We do not need MHRA approval to sell the Visitect test for professional use. We would only need MHRA approval, and to go through the PHE review process/get an EUA, if we were intending to sell them for non-professional use.
bedhead, you mind is playing tricks on you, so determined is it not to see what is in front of it.
I didn't type "your visitect", I typed "the visitect"
Oh yes , just wait ! Because CK an expert on leaving us all waiting & waiting & waiting , inept completely at the communication side of his role
@OkeHurst1: "do we need PHE approval to sell the Visitect test?"
Realistically who will buy a test that has failed approval? (and we don't know it has!), When the market is full of others that have met the mark?, Omega's sales teams aren't the most dynamic at the best of times, but i couldn't blame them for struggling with that
"Suggest this is down to Mologic and their agenda", I think you are probably right, but surely its the CEO role to stay on top of this type of thing that could impact the company.
We can only wait to find out the full story,
Comp, do we need PHE approval to sell the Visitect test?
Don’t think we do, it’s driven by the CE certificate.
Suggest this is down to Mologic and their agenda
@Okehurst1: Not really concerned with the DHSC contract, that will be what it is, when it is., Mologic, Avacta, Surescreen who cares.
The concern is the visitect antigen test, that could now be a white elephant, as the Visitect antibody test has proven to be.
If the DHSC contract takes 6 months to get up and running on, we should just be turning out Visitect, but are we going to be able to actually commercialise that without the PHE approval, One thing if they haven't submitted the test for approval, a complete different story if it failed.
That is 100% in Colin Kings control
Comp, suggest the variants and the ability of the standalone mologic test to identify the same, coupled with Avacta originally failing Porton in January then somehow in partnership with Mologic produce a test that is 100% accurate.
The Government were confident the AZ vaccine would provide protection against the SA variant for example, that doesn’t look like the case - sure the booster will
Lots of moving parts outside Colin’s control here, in this case I don’t he could have done much more, hence the silence, he’s waiting on the Avacta/ mologic test passing Porton so we can commence the £374M contract.
@Dsaf: You really are a muppet, who the hell is going to buy a test that has failed government approval when there are at least 30 other manufacturers available to choose from that have the seal of approval?
Computer, you really are a bout of negative idiocy.
If they cannot sell to the DHSC they will sell all they make to the private market and a much greater margin.
@Okehurst1: "this is not Colin’s fault"
If, and its only an if, Omega have spent 20+ weeks tech transferring a test that they cant sell in their own backyard, who else is to blame?
Comp909
Can’t disagree, as it stands today Mologic standalone test has not cleared Porton.
ODX were going to make this test for commercial use but it appears something has happened? We can only speculate it’s the > Ct 27 result from the Avacta/ Mologic test
Mologic may have said to Colin something along the lines
‘the upgraded test is 100% accurate, let’s roll that one out?’
It’s does look extremely likely - this all assumes Avacta clear Porton and the result matches their figures?
If so all will work out in the end and we have a delay of maybe 12 plus weeks from today in terms of the tests being sold?
As mentioned earlier this is not Colin’s fault.
That sounds plausible okehurst1. Hopefully we will be selling the moligic tests overseas before then should that happen.
Surely if the Mologic test had failed the PHE validation then even Colin wouldn't be able to keep that under wraps.
Walbrook have previously said that Omega were not engaged in the submission process, perhaps Mologic/ GAD haven't bothered as they don't see the UK as their market, if so that would surely be a major screw-up from ODX?
Think it’s fair to say that ODX is now linked to the Avacta & Mologic test ,the latter having partnered with Avacta in regards to their antigen biotech - according to their RNS today
The Mologic stand-alone biotech looks like it’s not going anywhere commercially, Avacta declaring 100% accuracy >27 Ct is the catalyst that was out of Colin’s hands
Speculating but it appears just a question of time that Avacta /Mologic test clears phase 3 Porton and then Omega get the green light off the Government.
The only issue is then timing? Is it a further 12 weeks for TT? This appears to be the rule of thumb but who knows?
None of this has been Colin’s fault, he couldn’t have foreseen the delay hence he has been quiet the last few weeks ,the £374M contract will commence this year but we could be looking at the end of July / August before we are generating income - it will come
There may have been directors selling this week or the back end of last week which has not been RNS'd yet.
There is a lag/delay between the sale and the RNS announcement.
Remember the last director sale was not RNS'd until the 19th April however the sale was actually processed on the 13th of April.
@Twatcher how many of the paused are lateral flow tests, 6 I believe, odds do not look as bad as you are suggesting.
Haha twatcher obviously not a holder saying
‘good luck selling your visitect brand’
No one listens to your nonsense, i just think obviously you have your delusional agenda with the rest of the mischievous rats!
Entertains me a little though...can feel your panic on the back of a 10 percent rise haha
Can’t wait for the SP to bag from here, £2+ incoming......you’ve and your cronies can tootle off with your tails between your legs hahaha
Weasels is a far better label for them. They will have sold at 79 now and be posting soon that it was a false alarm and it's going back to sub 70 while they are sat there watching level 2 waiting to get back in again. What a miserable life to live at the misfortune of others.